CONCURRENT SESSION I - STOP BUGGING ME: PATHOGENIC BACTERIA IN PEDIATRIC GASTROENTEROLOGY

H palooza 2018 - What's a doc to do?
Mark Gilger MD, Children’s Hospital of San Antonio
 Learning objectives:
 At completion of this session, the learner will be able to:
 1. Assess who to test / not test
 2. Demonstrate how to test
 3. Evaluate treatment options

FECAL MICROBIOTA TRANSPLANTATION FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN CHILDREN: SUSTAINED SPECIES LEVEL, ANTIMICROBIAL RESISTANCE AND PATHOGENMICROBIOME CHANGES. 
Suchitra Hourigan2,3,1, Michelle Ahn4, Keylie Gibson4, Marcos Pérez-Losada4, Grace Felix1, Andrew Spurr2, Melissa Weidner1, Ian Leibowitz3, John Niederhuber2, Cynthia Sears1, Keith Crandall4, Maria Oliva-Hemker1. 1Pediatrics, Johns Hopkins Hospital School of Medicine, Fairfax, VA, USA; 2Inova Translational Medicine Institute, Fairfax, VA, USA; 3Pediatric Specialists of Virginia, Fairfax, VA, USA; 4George Washington University, Washington, DC, , USA.

CLOSTRIDIUM DIFFICILE INFECTION: THE PEDIATRIC PERSPECTIVE
Maribeth Nicholson MD, Vanderbilt University
Learning objectives:
1. Describe current literature surrounding C. difficile epidemiology
2. Discuss recommendations surrounding C. difficile diagnosis and treatment
3. Identify controversies surrounding C. difficile colonization and disease

NOVEL, NON-ANTIBIOTIC, MECHANISM-BASED THERAPY TO TREAT HELICOBACTER PYLORI INFECTIONS
Nicola Jones MD, PhD, Hospital for Sick Children, Toronto, ON